CI 994

Known as: CI-994, CI994 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
[ (3)H]CI-994, a radioactive isotopologue of the benzamide CI-994, a class I histone deacetylase inhibitor (HDACi), was evaluated… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
BACKGROUND CI-994, an oral histone deacetylase inhibitor, has antineoplastic activity and synergism with gemcitabine… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
Review
2005
Review
2005
Histones are small basic proteins that, by complexing wtih DNA, form the nucleosome core. Repetitive units of this nucleosome led… (More)
Is this relevant?
2005
2005
CI-994 (N-acetyldinaline) is a novel oral compound with a wide spectrum of antitumor activity in preclinical models, in vitro and… (More)
Is this relevant?
2004
2004
BACKGROUND This study was conducted to determine the toxicity profile, maximum tolerated dose (MTD) and pharmacokinetics of the… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2004
2004
PURPOSE To determine maximum tolerated dose of CI-994, a novel oral histone deacetylase inhibitor, in combination with… (More)
Is this relevant?
2003
2003
PURPOSE The purpose of this study was to determine the maximum tolerated dose, pharmacokinetic profile, and evidence of antitumor… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Objectives: CI-994 (N-acetyl dinaline, PD123654) is a novel oral agent active in a broad variety ofmurine and human tumor… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
1997
1997
CI-994, a substituted benzamide derivative, is a compound that showed solid tumor selectivity for a variety of solid tumor models… (More)
Is this relevant?
1996
1996
CI-994 [aka: acetyldinaline; PD 123654; 4-acetylamino-N-(2′aminophenyl)-benzamide] (Figure 1) is a novel antitumor agent with a… (More)
  • figure 1
  • table I
  • table 2
  • table 3
  • table 4
Is this relevant?